Results 191 to 200 of about 24,362 (263)

Comparative Safety of Six First-Line Antiepileptic Monotherapies in Pediatric Epilepsy Using the United States FDA Adverse Event Reporting System. [PDF]

Cureus
Ogura T, Shiraishi C.
europepmc   +1 more source

Prenatal Prescription Opioid Analgesic Exposure and Academic Performance in Third Grade Children: A Population‐Based Cohort Study

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 8, Page 1658-1670, July 2026.
ABSTRACT Objective To evaluate the association between prenatal exposure to opioids analgesics and academic performance in third grade children. Design Population‐based cohort study using linked data from New South Wales birth records, medicine dispensing data, and national standardised test results.
Bianca Varney, Helga Zoega, Malcolm B. Gillies, Claudia Bruno, Alys Havard, Antonia Shand, Natasha Nassar, Jonathan Brett   +7 more
wiley   +1 more source

Age- and sex-associated variability in lamotrigine prescription patterns and clearance. [PDF]

Epilepsia
Avachat C, Long Y, Petersen A, Birnbaum AK, Patel SI.   +4 more
europepmc   +1 more source

WDTC1 Haploinsufficiency as a Cause of Neurodevelopmental Phenotypes

Clinical Genetics, Volume 110, Issue 1, Page 29-35, July 2026.
In seven individuals heterozygous for loss‐of‐function or conserved missense variants, we demonstrate that loss of WDTC1 function causes a neurodevelopmental syndrome characterized by developmental delay, intellectual disability, and seizures.
Elyssa Smith, Victor Faundes, Xiaonan Zhao, Bixia Zheng, Gang Zhang, Xiao Mao, Emily Danko, Jason Laufman, Thomas Besnard, Bertrand Isidor, Benjamin Cogné, Brynjar Örn Jensson, Telma S. Sulem, Patrick Sulem, Jill A. Rosenfeld, Daryl A. Scott   +15 more
wiley   +1 more source

Lamotrigine, Contraceptives, and Psychiatry: A Narrative Review. [PDF]

Cureus
Costa I, Esteves-Sousa D.
europepmc   +1 more source

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus

Contact Dermatitis, Volume 95, Issue 2, Page 231-233, August 2026.
Alexa G. Ries, Zachary Frost, Zachary Hopkins, Jamie P. Schlarbaum   +3 more
wiley   +1 more source

Suzetrigine as a novel treatment for headache disorders: A case series

Headache: The Journal of Head and Face Pain, Volume 66, Issue 7, Page 1644-1649, July/August 2026.
Abstract Suzetrigine is a selective voltage‐gated sodium channel blocker that was recently approved by the US Food and Drug Administration for the treatment of acute pain. We retrospectively evaluated the efficacy and tolerability of suzetrigine for the treatment of different headache disorders in patients refractory to standard treatments in an ...
Molly Fensterwald, Jordan Johnson, Angel Moreno, Shawn Conger‐Love, Charles Flippen, Chelsea Hesterman, Mollie Johnston, Joshua Kamins, Karla Minota, Peony Pak, Salman Hashim, Thanh‐Liem Huynh‐Tran, Noelle Kobayashi, Bradley Shane, Andrew Charles, Sinifunanya Nwaobi   +15 more
wiley   +1 more source

Ask a Simple Question, Design an Elegant Study and the Rest is History. [PDF]

Epilepsy Curr
Strozzi I, Joshi C.
europepmc   +1 more source

Self‐Poisoning With Prazosin and Its Off‐Label Use in Australia, 2014–2024: Analysis of NSW Poisons Information Centre Data

Medical Journal of Australia, Volume 224, Issue 7, July 2026.
ABSTRACT NSW Poisons Information Centre data identified 1030 deliberate prazosin self‐poisonings over 11 years, rising from 13 to 170 per year (2014–2024). Young women predominated, likely due to expanded off‐label (but accepted) psychiatric use of prazosin. Better evidence on benefits of off‐label use is needed to justify increasing risks.
Olivia B. E. Lal, Nicholas A. Buckley, Rose Cairns   +2 more
wiley   +1 more source

The Old and the New: Promising Interventions for Bipolar Disorder Combining Mood-Stabilizing Medication With Nutritional Ketosis. [PDF]

Biol Psychiatry Glob Open Sci
Phillips ML.
europepmc   +1 more source